nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxandrolone—AR—scrotum—urinary bladder cancer	0.223	0.477	CbGeAlD
Oxandrolone—AR—penis—urinary bladder cancer	0.1	0.215	CbGeAlD
Oxandrolone—Oligospermia—Gemcitabine—urinary bladder cancer	0.029	0.0742	CcSEcCtD
Oxandrolone—Azoospermia—Thiotepa—urinary bladder cancer	0.0268	0.0686	CcSEcCtD
Oxandrolone—AR—prostate gland—urinary bladder cancer	0.024	0.0514	CbGeAlD
Oxandrolone—Azoospermia—Gemcitabine—urinary bladder cancer	0.0226	0.0577	CcSEcCtD
Oxandrolone—Azoospermia—Cisplatin—urinary bladder cancer	0.021	0.0538	CcSEcCtD
Oxandrolone—AR—seminal vesicle—urinary bladder cancer	0.0203	0.0435	CbGeAlD
Oxandrolone—Necrosis—Mitomycin—urinary bladder cancer	0.0183	0.0468	CcSEcCtD
Oxandrolone—AR—epithelium—urinary bladder cancer	0.0176	0.0378	CbGeAlD
Oxandrolone—AR—smooth muscle tissue—urinary bladder cancer	0.017	0.0364	CbGeAlD
Oxandrolone—AR—renal system—urinary bladder cancer	0.0163	0.035	CbGeAlD
Oxandrolone—AR—urethra—urinary bladder cancer	0.0161	0.0344	CbGeAlD
Oxandrolone—Oligospermia—Methotrexate—urinary bladder cancer	0.0148	0.0379	CcSEcCtD
Oxandrolone—Irritability—Valrubicin—urinary bladder cancer	0.0144	0.0369	CcSEcCtD
Oxandrolone—Oligospermia—Epirubicin—urinary bladder cancer	0.0139	0.0355	CcSEcCtD
Oxandrolone—AR—female reproductive system—urinary bladder cancer	0.0131	0.028	CbGeAlD
Oxandrolone—Oligospermia—Doxorubicin—urinary bladder cancer	0.0128	0.0328	CcSEcCtD
Oxandrolone—Bronchial hyperreactivity—Methotrexate—urinary bladder cancer	0.0119	0.0305	CcSEcCtD
Oxandrolone—AR—vagina—urinary bladder cancer	0.0118	0.0254	CbGeAlD
Oxandrolone—Azoospermia—Methotrexate—urinary bladder cancer	0.0115	0.0295	CcSEcCtD
Oxandrolone—Chronic obstructive pulmonary disease—Methotrexate—urinary bladder cancer	0.0109	0.0278	CcSEcCtD
Oxandrolone—Azoospermia—Epirubicin—urinary bladder cancer	0.0108	0.0276	CcSEcCtD
Oxandrolone—Azoospermia—Doxorubicin—urinary bladder cancer	0.00999	0.0256	CcSEcCtD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDX1—urinary bladder cancer	0.00973	0.0854	CbGpPWpGaD
Oxandrolone—Trilostane—ESR2—urinary bladder cancer	0.00925	0.327	CrCbGaD
Oxandrolone—AR—lymph node—urinary bladder cancer	0.00766	0.0164	CbGeAlD
Oxandrolone—Necrosis—Fluorouracil—urinary bladder cancer	0.00761	0.0195	CcSEcCtD
Oxandrolone—Necrosis—Cisplatin—urinary bladder cancer	0.00722	0.0185	CcSEcCtD
Oxandrolone—Fluid retention—Thiotepa—urinary bladder cancer	0.00686	0.0175	CcSEcCtD
Oxandrolone—Necrosis—Etoposide—urinary bladder cancer	0.00661	0.0169	CcSEcCtD
Oxandrolone—Creatinine increased—Gemcitabine—urinary bladder cancer	0.00638	0.0163	CcSEcCtD
Oxandrolone—Allylestrenol—ESR1—urinary bladder cancer	0.00585	0.206	CrCbGaD
Oxandrolone—Fluid retention—Gemcitabine—urinary bladder cancer	0.00577	0.0148	CcSEcCtD
Oxandrolone—Trilostane—ESR1—urinary bladder cancer	0.0057	0.201	CrCbGaD
Oxandrolone—Fluid retention—Cisplatin—urinary bladder cancer	0.00538	0.0138	CcSEcCtD
Oxandrolone—AR—Integrated Breast Cancer Pathway—PHB—urinary bladder cancer	0.00522	0.0458	CbGpPWpGaD
Oxandrolone—Oedema—Mitomycin—urinary bladder cancer	0.00512	0.0131	CcSEcCtD
Oxandrolone—Blood creatinine increased—Thiotepa—urinary bladder cancer	0.00491	0.0126	CcSEcCtD
Oxandrolone—AR—Nuclear Receptors—ESR2—urinary bladder cancer	0.00418	0.0367	CbGpPWpGaD
Oxandrolone—Irritability—Fluorouracil—urinary bladder cancer	0.00414	0.0106	CcSEcCtD
Oxandrolone—Blood creatinine increased—Gemcitabine—urinary bladder cancer	0.00413	0.0106	CcSEcCtD
Oxandrolone—Necrosis—Methotrexate—urinary bladder cancer	0.00396	0.0101	CcSEcCtD
Oxandrolone—Irritability—Cisplatin—urinary bladder cancer	0.00392	0.01	CcSEcCtD
Oxandrolone—Blood creatinine increased—Cisplatin—urinary bladder cancer	0.00385	0.00985	CcSEcCtD
Oxandrolone—Necrosis—Epirubicin—urinary bladder cancer	0.00371	0.00948	CcSEcCtD
Oxandrolone—Haemoglobin—Thiotepa—urinary bladder cancer	0.00365	0.00932	CcSEcCtD
Oxandrolone—Haemorrhage—Thiotepa—urinary bladder cancer	0.00363	0.00928	CcSEcCtD
Oxandrolone—Necrosis—Doxorubicin—urinary bladder cancer	0.00343	0.00877	CcSEcCtD
Oxandrolone—Jaundice cholestatic—Epirubicin—urinary bladder cancer	0.00331	0.00847	CcSEcCtD
Oxandrolone—AR—Nuclear Receptor transcription pathway—ESR2—urinary bladder cancer	0.0033	0.029	CbGpPWpGaD
Oxandrolone—Fluoxymesterone—ESR1—urinary bladder cancer	0.00307	0.108	CrCbGaD
Oxandrolone—Haemoglobin—Gemcitabine—urinary bladder cancer	0.00307	0.00784	CcSEcCtD
Oxandrolone—Jaundice cholestatic—Doxorubicin—urinary bladder cancer	0.00306	0.00783	CcSEcCtD
Oxandrolone—Creatinine increased—Epirubicin—urinary bladder cancer	0.00306	0.00781	CcSEcCtD
Oxandrolone—Haemorrhage—Gemcitabine—urinary bladder cancer	0.00305	0.0078	CcSEcCtD
Oxandrolone—Haemoglobin—Fluorouracil—urinary bladder cancer	0.00302	0.00771	CcSEcCtD
Oxandrolone—Haemorrhage—Fluorouracil—urinary bladder cancer	0.003	0.00767	CcSEcCtD
Oxandrolone—Danazol—ESR1—urinary bladder cancer	0.00294	0.104	CrCbGaD
Oxandrolone—Creatinine increased—Doxorubicin—urinary bladder cancer	0.00283	0.00723	CcSEcCtD
Oxandrolone—Neoplasm—Methotrexate—urinary bladder cancer	0.00281	0.00719	CcSEcCtD
Oxandrolone—Gynaecomastia—Methotrexate—urinary bladder cancer	0.00278	0.00711	CcSEcCtD
Oxandrolone—Fluid retention—Epirubicin—urinary bladder cancer	0.00276	0.00706	CcSEcCtD
Oxandrolone—AR—Notch-mediated HES/HEY network—NCOR1—urinary bladder cancer	0.00272	0.0239	CbGpPWpGaD
Oxandrolone—Neoplasm—Epirubicin—urinary bladder cancer	0.00263	0.00673	CcSEcCtD
Oxandrolone—Fluid retention—Doxorubicin—urinary bladder cancer	0.00256	0.00653	CcSEcCtD
Oxandrolone—AR—Nuclear Receptors—ESR1—urinary bladder cancer	0.00253	0.0222	CbGpPWpGaD
Oxandrolone—Neoplasm—Doxorubicin—urinary bladder cancer	0.00243	0.00622	CcSEcCtD
Oxandrolone—AR—Nuclear Receptors—PPARG—urinary bladder cancer	0.00231	0.0203	CbGpPWpGaD
Oxandrolone—AR—FOXA1 transcription factor network—ESR1—urinary bladder cancer	0.00225	0.0198	CbGpPWpGaD
Oxandrolone—Oedema—Gemcitabine—urinary bladder cancer	0.00217	0.00554	CcSEcCtD
Oxandrolone—Irritability—Methotrexate—urinary bladder cancer	0.00215	0.00551	CcSEcCtD
Oxandrolone—Oedema—Fluorouracil—urinary bladder cancer	0.00213	0.00545	CcSEcCtD
Oxandrolone—Oedema—Cisplatin—urinary bladder cancer	0.00202	0.00517	CcSEcCtD
Oxandrolone—AR—Nuclear Receptor transcription pathway—ESR1—urinary bladder cancer	0.002	0.0176	CbGpPWpGaD
Oxandrolone—Blood creatinine increased—Epirubicin—urinary bladder cancer	0.00198	0.00506	CcSEcCtD
Oxandrolone—AR—FOXA1 transcription factor network—CREBBP—urinary bladder cancer	0.00198	0.0173	CbGpPWpGaD
Oxandrolone—Insomnia—Gemcitabine—urinary bladder cancer	0.00196	0.00501	CcSEcCtD
Oxandrolone—Insomnia—Fluorouracil—urinary bladder cancer	0.00193	0.00493	CcSEcCtD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—LIG1—urinary bladder cancer	0.00188	0.0165	CbGpPWpGaD
Oxandrolone—AR—Notch-mediated HES/HEY network—CREBBP—urinary bladder cancer	0.00187	0.0164	CbGpPWpGaD
Oxandrolone—AR—Notch-mediated HES/HEY network—RB1—urinary bladder cancer	0.00187	0.0164	CbGpPWpGaD
Oxandrolone—Blood creatinine increased—Doxorubicin—urinary bladder cancer	0.00183	0.00468	CcSEcCtD
Oxandrolone—AR—Nuclear Receptor transcription pathway—PPARG—urinary bladder cancer	0.00183	0.016	CbGpPWpGaD
Oxandrolone—Erectile dysfunction—Methotrexate—urinary bladder cancer	0.0018	0.00459	CcSEcCtD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—NCOR1—urinary bladder cancer	0.00176	0.0155	CbGpPWpGaD
Oxandrolone—AR—Nongenotropic Androgen signaling—SRC—urinary bladder cancer	0.00173	0.0152	CbGpPWpGaD
Oxandrolone—AR—Regulation of Androgen receptor activity—CREBBP—urinary bladder cancer	0.0017	0.0149	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—CCNE1—urinary bladder cancer	0.00168	0.0148	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—NCOR1—urinary bladder cancer	0.00163	0.0143	CbGpPWpGaD
Oxandrolone—Haemoglobin—Methotrexate—urinary bladder cancer	0.00157	0.00401	CcSEcCtD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—urinary bladder cancer	0.00157	0.0138	CbGpPWpGaD
Oxandrolone—Haemorrhage—Methotrexate—urinary bladder cancer	0.00156	0.00399	CcSEcCtD
Oxandrolone—AR—Integrated Breast Cancer Pathway—TSC1—urinary bladder cancer	0.00154	0.0135	CbGpPWpGaD
Oxandrolone—Progesterone—ESR1—urinary bladder cancer	0.00152	0.0537	CrCbGaD
Oxandrolone—Haemoglobin—Epirubicin—urinary bladder cancer	0.00147	0.00375	CcSEcCtD
Oxandrolone—Haemorrhage—Epirubicin—urinary bladder cancer	0.00146	0.00374	CcSEcCtD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—HPGDS—urinary bladder cancer	0.00143	0.0126	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	0.00143	0.0125	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—CDK4—urinary bladder cancer	0.00139	0.0122	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—ESR1—urinary bladder cancer	0.00138	0.0121	CbGpPWpGaD
Oxandrolone—Haemoglobin—Doxorubicin—urinary bladder cancer	0.00136	0.00347	CcSEcCtD
Oxandrolone—Haemorrhage—Doxorubicin—urinary bladder cancer	0.00135	0.00346	CcSEcCtD
Oxandrolone—AR—SIDS Susceptibility Pathways—ESR2—urinary bladder cancer	0.00135	0.0119	CbGpPWpGaD
Oxandrolone—AR—FOXA1 transcription factor network—EP300—urinary bladder cancer	0.00135	0.0118	CbGpPWpGaD
Oxandrolone—AR—Coregulation of Androgen receptor activity—CDKN2A—urinary bladder cancer	0.00133	0.0117	CbGpPWpGaD
Oxandrolone—AR—Notch-mediated HES/HEY network—EP300—urinary bladder cancer	0.00128	0.0112	CbGpPWpGaD
Oxandrolone—AR—Nongenotropic Androgen signaling—HRAS—urinary bladder cancer	0.00122	0.0107	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—urinary bladder cancer	0.00122	0.0107	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—CREBBP—urinary bladder cancer	0.00121	0.0106	CbGpPWpGaD
Oxandrolone—AR—Regulation of Androgen receptor activity—EP300—urinary bladder cancer	0.00116	0.0102	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	0.00115	0.0101	CbGpPWpGaD
Oxandrolone—AR—Regulation of Androgen receptor activity—SRC—urinary bladder cancer	0.00113	0.00989	CbGpPWpGaD
Oxandrolone—AR—Coregulation of Androgen receptor activity—CCND1—urinary bladder cancer	0.00113	0.00988	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—CREBBP—urinary bladder cancer	0.00112	0.00987	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—RB1—urinary bladder cancer	0.00112	0.00983	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—urinary bladder cancer	0.00107	0.00941	CbGpPWpGaD
Oxandrolone—Oedema—Epirubicin—urinary bladder cancer	0.00104	0.00265	CcSEcCtD
Oxandrolone—AR—Androgen receptor signaling pathway—RHOA—urinary bladder cancer	0.00102	0.00893	CbGpPWpGaD
Oxandrolone—Insomnia—Methotrexate—urinary bladder cancer	0.001	0.00256	CcSEcCtD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—urinary bladder cancer	0.000972	0.00854	CbGpPWpGaD
Oxandrolone—Oedema—Doxorubicin—urinary bladder cancer	0.00096	0.00246	CcSEcCtD
Oxandrolone—Insomnia—Epirubicin—urinary bladder cancer	0.000939	0.0024	CcSEcCtD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	0.000913	0.00802	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—urinary bladder cancer	0.000906	0.00795	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	0.000897	0.00787	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—urinary bladder cancer	0.000879	0.00772	CbGpPWpGaD
Oxandrolone—Insomnia—Doxorubicin—urinary bladder cancer	0.000868	0.00222	CcSEcCtD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—CDKN1A—urinary bladder cancer	0.000868	0.00762	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—ATM—urinary bladder cancer	0.000847	0.00744	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—CDK4—urinary bladder cancer	0.000844	0.00741	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—ESR1—urinary bladder cancer	0.00084	0.00738	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—urinary bladder cancer	0.000834	0.00732	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—CCND1—urinary bladder cancer	0.000832	0.0073	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—EP300—urinary bladder cancer	0.000826	0.00725	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—CDKN1A—urinary bladder cancer	0.000805	0.00706	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—PTEN—urinary bladder cancer	0.000803	0.00705	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	0.000795	0.00698	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—EP300—urinary bladder cancer	0.000766	0.00672	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—SRC—urinary bladder cancer	0.000745	0.00654	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—RB1—urinary bladder cancer	0.000734	0.00644	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—CDH1—urinary bladder cancer	0.000731	0.00642	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—urinary bladder cancer	0.000727	0.00638	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—MYC—urinary bladder cancer	0.000719	0.00632	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—CREBBP—urinary bladder cancer	0.000718	0.0063	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	0.000702	0.00616	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	0.000699	0.00614	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	0.000696	0.00611	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—EGFR—urinary bladder cancer	0.000653	0.00573	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	0.00061	0.00536	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	0.000603	0.00529	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—ESR2—urinary bladder cancer	0.00057	0.00501	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—CXCL8—urinary bladder cancer	0.00057	0.005	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—CCND1—urinary bladder cancer	0.000545	0.00478	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—PTEN—urinary bladder cancer	0.000526	0.00462	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	0.000511	0.00449	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—EP300—urinary bladder cancer	0.000502	0.0044	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	0.0005	0.00439	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	0.000489	0.00429	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	0.000452	0.00396	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—NCOR1—urinary bladder cancer	0.00044	0.00387	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—MYC—urinary bladder cancer	0.000437	0.00384	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	0.000437	0.00383	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	0.000436	0.00383	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—EGFR—urinary bladder cancer	0.000428	0.00375	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	0.000416	0.00365	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	0.000404	0.00355	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—KRAS—urinary bladder cancer	0.000404	0.00355	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	0.000397	0.00348	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	0.000362	0.00318	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—TP53—urinary bladder cancer	0.000359	0.00315	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	0.000354	0.00311	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—ESR1—urinary bladder cancer	0.000346	0.00304	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	0.000337	0.00296	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	0.000335	0.00294	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—PPARG—urinary bladder cancer	0.000316	0.00277	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—SMC1A—urinary bladder cancer	0.000315	0.00277	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—CREBBP—urinary bladder cancer	0.000303	0.00266	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	0.000297	0.00261	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—ESR2—urinary bladder cancer	0.000275	0.00241	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—NCOR1—urinary bladder cancer	0.000212	0.00186	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—ERCC2—urinary bladder cancer	0.000199	0.00175	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—MYC—urinary bladder cancer	0.00018	0.00158	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—ESR1—urinary bladder cancer	0.000167	0.00146	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—PPARG—urinary bladder cancer	0.000152	0.00133	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—CREBBP—urinary bladder cancer	0.000146	0.00128	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—MYC—urinary bladder cancer	8.66e-05	0.00076	CbGpPWpGaD
